However, many pro-inflammatory markers such as C-reactive protein, eotaxin, IFN-gamma, MCP-1, and serum amyloid P, were actually lower in MPS IVA patients. This evidence concerns the gene CCL2 and mucopolysaccharidosis type 4A.